TCL Archive Eye Institute Director Kupfer Steps Down; UICC Begins Web-Based Surgical Pathology. July 7, 2000
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Ohio Plans To Build Four New Cancer Centers With $140 Million Bond Issue If Voters Approve February 21, 1975
